Cargando…

A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder

BACKGROUND: Evidence is accumulating that Cognitive Remediation Training (CRT) is effective for ameliorating cognitive deficits experienced by patients with schizophrenia and accompanying functional impairment. There has been no randomized controlled trial of CRT using a nationally representative po...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Reilly, Ken, Donohoe, Gary, O’Sullivan, Danny, Coyle, Ciaran, Corvin, Aiden, O’Flynn, Padraic, O’Donnell, Muireann, Galligan, Toni, O’Connell, Paul, Kennedy, Harry G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334394/
https://www.ncbi.nlm.nih.gov/pubmed/30646884
http://dx.doi.org/10.1186/s12888-019-2018-6
_version_ 1783387704554160128
author O’Reilly, Ken
Donohoe, Gary
O’Sullivan, Danny
Coyle, Ciaran
Corvin, Aiden
O’Flynn, Padraic
O’Donnell, Muireann
Galligan, Toni
O’Connell, Paul
Kennedy, Harry G.
author_facet O’Reilly, Ken
Donohoe, Gary
O’Sullivan, Danny
Coyle, Ciaran
Corvin, Aiden
O’Flynn, Padraic
O’Donnell, Muireann
Galligan, Toni
O’Connell, Paul
Kennedy, Harry G.
author_sort O’Reilly, Ken
collection PubMed
description BACKGROUND: Evidence is accumulating that Cognitive Remediation Training (CRT) is effective for ameliorating cognitive deficits experienced by patients with schizophrenia and accompanying functional impairment. There has been no randomized controlled trial of CRT using a nationally representative population of forensic patients, despite the significant cognitive deficits frequently present within this group. METHODS: Sixty-five patients with schizophrenia or schizoaffective disorder were enrolled in a single blind randomized controlled trial of CRT versus treatment as usual (TAU); representing 94% of those eligible within a national forensic cohort. The primary outcome measure was the composite score of the MATRICS Consensus Cognitive Battery (MCCB). Secondary outcome measures included neurocognitive and social cognitive domains, symptoms, and ‘real world’ functioning. Patient satisfaction was examined using an exit interview. Participants were reassessed at 8 months follow up. All data were analyzed using an intention to treat design (ITT). RESULTS: For the primary outcome measure, the MCCB composite score, there were significant differences between those who participated in CRT and those receiving TAU at both end of treatment and 8 months follow up (Cohen’s d = 0.34. Significant improvements were observed in visual and working memory. Mediation analysis found that those who cognitively benefited from CRT had corresponding improved functioning, and more net positive therapeutic moves i.e. moves to units with lower security within the hospital. Ninety-six percent believed their cognitive gains positively affected their daily lives. CONCLUSIONS: CRT may be an acceptable and efficacious intervention for forensic patients with schizophrenia or schizoaffective disorder. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02360813. Trial registered Feb 4th 2015, last updated May 1st 2015.
format Online
Article
Text
id pubmed-6334394
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63343942019-01-23 A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder O’Reilly, Ken Donohoe, Gary O’Sullivan, Danny Coyle, Ciaran Corvin, Aiden O’Flynn, Padraic O’Donnell, Muireann Galligan, Toni O’Connell, Paul Kennedy, Harry G. BMC Psychiatry Research Article BACKGROUND: Evidence is accumulating that Cognitive Remediation Training (CRT) is effective for ameliorating cognitive deficits experienced by patients with schizophrenia and accompanying functional impairment. There has been no randomized controlled trial of CRT using a nationally representative population of forensic patients, despite the significant cognitive deficits frequently present within this group. METHODS: Sixty-five patients with schizophrenia or schizoaffective disorder were enrolled in a single blind randomized controlled trial of CRT versus treatment as usual (TAU); representing 94% of those eligible within a national forensic cohort. The primary outcome measure was the composite score of the MATRICS Consensus Cognitive Battery (MCCB). Secondary outcome measures included neurocognitive and social cognitive domains, symptoms, and ‘real world’ functioning. Patient satisfaction was examined using an exit interview. Participants were reassessed at 8 months follow up. All data were analyzed using an intention to treat design (ITT). RESULTS: For the primary outcome measure, the MCCB composite score, there were significant differences between those who participated in CRT and those receiving TAU at both end of treatment and 8 months follow up (Cohen’s d = 0.34. Significant improvements were observed in visual and working memory. Mediation analysis found that those who cognitively benefited from CRT had corresponding improved functioning, and more net positive therapeutic moves i.e. moves to units with lower security within the hospital. Ninety-six percent believed their cognitive gains positively affected their daily lives. CONCLUSIONS: CRT may be an acceptable and efficacious intervention for forensic patients with schizophrenia or schizoaffective disorder. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02360813. Trial registered Feb 4th 2015, last updated May 1st 2015. BioMed Central 2019-01-15 /pmc/articles/PMC6334394/ /pubmed/30646884 http://dx.doi.org/10.1186/s12888-019-2018-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
O’Reilly, Ken
Donohoe, Gary
O’Sullivan, Danny
Coyle, Ciaran
Corvin, Aiden
O’Flynn, Padraic
O’Donnell, Muireann
Galligan, Toni
O’Connell, Paul
Kennedy, Harry G.
A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder
title A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder
title_full A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder
title_fullStr A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder
title_full_unstemmed A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder
title_short A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder
title_sort randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334394/
https://www.ncbi.nlm.nih.gov/pubmed/30646884
http://dx.doi.org/10.1186/s12888-019-2018-6
work_keys_str_mv AT oreillyken arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT donohoegary arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT osullivandanny arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT coyleciaran arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT corvinaiden arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT oflynnpadraic arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT odonnellmuireann arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT galligantoni arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT oconnellpaul arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT kennedyharryg arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT oreillyken randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT donohoegary randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT osullivandanny randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT coyleciaran randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT corvinaiden randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT oflynnpadraic randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT odonnellmuireann randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT galligantoni randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT oconnellpaul randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder
AT kennedyharryg randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder